
Smug Pharma Private Limited
Provides financial services with registered office in Delhi since 2000.
Provides financial services with registered office in Delhi since 2000.
Delhi, India
+91-XXXXXXXXXX
U24239DL2000PTC105125
105125
Private Limited Indian Non-Government Company
10 Apr 2000
20 Nov 2020
31 Mar 2020
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pramod Basotia ![]() | Director | 06-Mar-2012 | Current |
Ashok Sharma ![]() | Director | 20-Nov-2002 | Current |
Smug Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Smug Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Pramod Basotia and Ashok Sharma are mutual person
Pramod Basotia and Ashok Sharma are mutual person
Pramod Basotia and Ashok Sharma are mutual person
Ashok Sharma is a mutual person
Ashok Sharma is a mutual person
Ashok Sharma is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Smug Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Smug Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smug Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Smug Pharma Private Limited last Annual general meeting of members was held on 20 Nov 2020 as per latest MCA records.
Smug Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi.
Pramod Kumar Basotia was appointed as a Director was appointed as a Director on 06 Mar 2012 & has been associated with this company since 13 years 2 months .
Ashok Kumar Sharma was appointed as a Director was appointed as a Director on 20 Nov 2002 & has been associated with this company since 22 years 6 months .
Smug Pharma Private Limited was registered on 10 Apr 2000 with Roc Delhi & aged 25 years 1 month as per MCA records.
Smug Pharma Private Limited was incorporated on 10 Apr 2000.
The authorized share capital of Smug Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.99 M.
Currently 2 directors are associated with Smug Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Smug Pharma Private Limited is Dda Market No 3/18 Sec-2Rohini India, New Delhi, 110085.
The corporate identification number (CIN) of Smug Pharma Private Limited is U24239DL2000PTC105125 and the company number is 105125 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Smug Pharma Private Limited was filed with the ROC on 31 Mar 2020.
Search company & director profiles for free and gain access to critical business data.
DS